Satoshi Obika

8.2k total citations · 1 hit paper
327 papers, 6.3k citations indexed

About

Satoshi Obika is a scholar working on Molecular Biology, Organic Chemistry and Ecology. According to data from OpenAlex, Satoshi Obika has authored 327 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 304 papers in Molecular Biology, 41 papers in Organic Chemistry and 16 papers in Ecology. Recurrent topics in Satoshi Obika's work include DNA and Nucleic Acid Chemistry (227 papers), Advanced biosensing and bioanalysis techniques (226 papers) and RNA Interference and Gene Delivery (144 papers). Satoshi Obika is often cited by papers focused on DNA and Nucleic Acid Chemistry (227 papers), Advanced biosensing and bioanalysis techniques (226 papers) and RNA Interference and Gene Delivery (144 papers). Satoshi Obika collaborates with scholars based in Japan, United States and Bangladesh. Satoshi Obika's co-authors include Takeshi Imanishi, Yoshiyuki Hari, Ken‐ichiro Morio, Daishu Nanbu, Yuuya Kasahara, Takefumi Doi, Tsuyoshi Yamamoto, Masayasu Kuwahara, Kunihiko Morihiro and Mitsuaki Sekiguchi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nucleic Acids Research.

In The Last Decade

Satoshi Obika

313 papers receiving 6.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Stability and structural features of the duplexes containing nucleoside analogues with a fixed N-type conformation, 2′-O,4′-C-methyleneribonucleosides

1998 579 citations Satoshi Obika, Yoshiyuki Hari et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Satoshi Obika Japan	39	5.5k	732	364	352	307	327	6.3k
Mark D. Matteucci United States	35	4.4k 0.8×	906 1.2×	264 0.7×	421 1.2×	327 1.1×	66	5.2k
Sergei Gryaznov United States	41	3.9k 0.7×	278 0.4×	119 0.3×	146 0.4×	344 1.1×	107	4.7k
Shigeo Matsuda United States	26	2.6k 0.5×	341 0.5×	109 0.3×	236 0.7×	100 0.3×	41	2.9k
Glen Spraggon United States	37	2.3k 0.4×	390 0.5×	90 0.2×	327 0.9×	454 1.5×	70	4.0k
Rakesh N. Veedu Australia	32	3.6k 0.7×	205 0.3×	193 0.5×	649 1.8×	108 0.4×	114	4.2k
Punit P. Seth United States	44	5.0k 0.9×	654 0.9×	70 0.2×	519 1.5×	149 0.5×	120	5.9k
Thazha P. Prakash United States	46	5.4k 1.0×	338 0.5×	104 0.3×	748 2.1×	122 0.4×	114	6.0k
Clifford D. Mol United States	26	5.0k 0.9×	343 0.5×	283 0.8×	283 0.8×	1.1k 3.6×	31	6.3k
Christian Heinis Switzerland	37	4.3k 0.8×	1.8k 2.5×	171 0.5×	96 0.3×	687 2.2×	99	5.5k
Tom N. Grossmann Germany	36	4.4k 0.8×	1.6k 2.1×	126 0.3×	116 0.3×	623 2.0×	90	5.1k

Countries citing papers authored by Satoshi Obika

Since Specialization

Citations

This map shows the geographic impact of Satoshi Obika's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoshi Obika with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoshi Obika more than expected).

Fields of papers citing papers by Satoshi Obika

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satoshi Obika. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoshi Obika. The network helps show where Satoshi Obika may publish in the future.

Co-authorship network of co-authors of Satoshi Obika

This figure shows the co-authorship network connecting the top 25 collaborators of Satoshi Obika. A scholar is included among the top collaborators of Satoshi Obika based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satoshi Obika. Satoshi Obika is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Masuda, Junichi, et al.. (2025). Separation of deaminated impurities from the desired oligonucleotides using supercritical fluid chromatography. Journal of Chromatography A. 1744. 465731–465731. 2 indexed citations

Uchida, Y., et al.. (2025). Multispanning membrane protein SIDT2 increases knockdown activity of gapmer antisense oligonucleotides. Scientific Reports. 15(1). 586–586. 1 indexed citations

Hara, Tomoaki, Yuuya Kasahara, Takashi Osawa, et al.. (2025). Antisense oligonucleotide targeting nicotinamide N-methyltransferase exhibits antitumor effects. Molecular Therapy — Nucleic Acids. 36(2). 102548–102548.

Miki, Koji, Huiying Mu, Takashi Osawa, et al.. (2024). Light-controllable cell-membrane disturbance for intracellular delivery. Journal of Materials Chemistry B. 12(17). 4138–4147. 1 indexed citations

Hori, Mao, Nan Qiao, Beob Soo Kim, et al.. (2024). Hydrophobicity Tuning of Cationic Polyaspartamide Derivatives for Enhanced Antisense Oligonucleotide Delivery. Bioconjugate Chemistry. 35(2). 125–131. 4 indexed citations

Obika, Satoshi, et al.. (2024). Splice-switching antisense oligonucleotide controlling tumor suppressor REST is a novel therapeutic medicine for neuroendocrine cancer. Molecular Therapy — Nucleic Acids. 35(3). 102250–102250. 3 indexed citations

Sasaki, Takashi, Takashi Kurita, Katsuya Yamada, et al.. (2023). Synthesis and properties of a novel modified nucleic acid, 2′-N-methanesulfonyl-2′-amino-locked nucleic acid. Bioorganic & Medicinal Chemistry Letters. 88. 129289–129289. 3 indexed citations

Kasahara, Yuuya, et al.. (2023). Systematic Analysis of 2′-O-Alkyl Modified Analogs for Enzymatic Synthesis and Their Oligonucleotide Properties. Molecules. 28(23). 7911–7911. 1 indexed citations

Takakusa, Hideo, et al.. (2023). Drug Metabolism and Pharmacokinetics of Antisense Oligonucleotide Therapeutics: Typical Profiles, Evaluation Approaches, and Points to Consider Compared with Small Molecule Drugs. Nucleic Acid Therapeutics. 33(2). 83–94. 63 indexed citations

10.

Hussain, Fahad, Fahad Imtiaz Rahman, Atsushi Mikami, et al.. (2022). Synthesis of Sugar and Nucleoside Analogs and Evaluation of Their Anticancer and Analgesic Potentials. Molecules. 27(11). 3499–3499. 3 indexed citations

11.

Itoh, Yukihiro, Yoshie Fujiwara, Yukari Takahashi, et al.. (2021). Identification of Potent and Selective Inhibitors of Fat Mass Obesity-Associated Protein Using a Fragment-Merging Approach. Journal of Medicinal Chemistry. 64(21). 15810–15824. 27 indexed citations

12.

Hirabayashi, Yoko, Kazushige Maki, Kiyoshi Kinoshita, et al.. (2021). Considerations of the Japanese Research Working Group for the ICH S6 & Related Issues Regarding Nonclinical Safety Assessments of Oligonucleotide Therapeutics: Comparison with Those of Biopharmaceuticals. Nucleic Acid Therapeutics. 31(2). 114–125. 7 indexed citations

13.

Harada, Takeshi, Shinji Matsumoto, Hirokazu Kimura, et al.. (2019). Chemically Modified Antisense Oligonucleotide Against ARL4C Inhibits Primary and Metastatic Liver Tumor Growth. Molecular Cancer Therapeutics. 18(3). 602–612. 35 indexed citations

14.

Kawashima, Yusuke, Yuuya Kasahara, Tatsuya Takagi, et al.. (2019). Inhibiting guanine oxidation and enhancing the excess-electron-transfer efficiency of a pyrene-modified oligonucleotide by introducing an electron-donating group on pyrene. Chemical Communications. 55(93). 14062–14065. 6 indexed citations

15.

Matsumoto, Shinji, Koei Shinzawa, Yuuya Kasahara, et al.. (2019). GREB1 induced by Wnt signaling promotes development of hepatoblastoma by suppressing TGFβ signaling. Nature Communications. 10(1). 3882–3882. 25 indexed citations

16.

Osawa, Takashi, Satoshi Obika, & Yoshiyuki Hari. (2019). 2′-C,4′-C-Ethyleneoxy-Bridged 2′-Deoxyribonucleic Acids (EoDNAs) with Thymine Nucleobases: Synthesis, Duplex-Forming Ability, and Enzymatic Stability. Methods in molecular biology. 1973. 59–89. 1 indexed citations

17.

Hosoki, Kana, et al.. (2018). A novel human muscle cell model of Duchenne muscular dystrophy created by CRISPR/Cas9 and evaluation of antisense-mediated exon skipping. Journal of Human Genetics. 63(3). 365–375. 21 indexed citations

18.

Morihiro, Kunihiko, Yuuya Kasahara, & Satoshi Obika. (2016). Biological applications of xeno nucleic acids. Molecular BioSystems. 13(2). 235–245. 97 indexed citations

19.

Hagiwara, Kenta, et al.. (2014). In vitro selection of DNA-based aptamers that exhibit RNA-like conformations using a chimeric oligonucleotide library that contains two different xeno-nucleic acids. Molecular BioSystems. 11(1). 71–76. 28 indexed citations

20.

Hari, Yoshiyuki, et al.. (2001). Triplex formation involving 2',4'-BNA with 2-pyridone base analogue: Efficient and selective recognition of C:G interruption. Nucleic Acids Symposium Series. 1(1). 281–282. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact